Ameritas Investment Partners’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-18,964
| Closed | -$879K | – | 3097 |
|
|
2019
Q2 | $879K | Buy |
18,964
+1,543
| +9% | +$43.3K | 0.04% | 563 |
|
|
2019
Q1 | $425K | Buy |
17,421
+422
| +2% | +$8.79K | 0.02% | 770 |
|
|
2018
Q4 | $242K | Hold |
16,999
| – | – | 0.01% | 886 |
|
|
2018
Q3 | $258K | Hold |
16,999
| – | – | 0.01% | 949 |
|
|
2018
Q2 | $285K | Sell |
16,999
-254
| -1% | -$4.04K | 0.01% | 887 |
|
|
2018
Q1 | $282K | Hold |
17,253
| – | – | 0.01% | 926 |
|
|
2017
Q4 | $221K | Buy |
17,253
+2,105
| +14% | +$23.9K | 0.01% | 1040 |
|
|
2017
Q3 | $146K | Hold |
15,148
| – | – | 0.01% | 1240 |
|
|
2017
Q2 | $127K | Buy |
15,148
+1,012
| +7% | +$8.28K | 0.01% | 1321 |
|
|
2017
Q1 | $126K | Hold |
14,136
| – | – | 0.01% | 1298 |
|
|
2016
Q4 | $124K | Buy |
14,136
+3,250
| +30% | +$23.9K | 0.01% | 1068 |
|
|
2016
Q3 | $73K | Hold |
10,886
| – | – | ﹤0.01% | 1082 |
|
|
2016
Q2 | $39K | Hold |
10,886
| – | – | ﹤0.01% | 1046 |
|
|
2016
Q1 | $32K | Hold |
10,886
| – | – | ﹤0.01% | 1053 |
|
|
2015
Q4 | $46K | Hold |
10,886
| – | – | ﹤0.01% | 1025 |
|
|
2015
Q3 | $50K | Hold |
10,886
| – | – | ﹤0.01% | 1002 |
|
|
2015
Q2 | $78K | Sell |
10,886
-1,429
| -12% | -$10.5K | 0.01% | 1028 |
|
|
2015
Q1 | $91K | Buy |
12,315
+1,991
| +19% | +$14.2K | 0.01% | 1061 |
|
|
2014
Q4 | $49K | Hold |
10,324
| – | – | ﹤0.01% | 1071 |
|
|
2014
Q3 | $37K | Hold |
10,324
| – | – | ﹤0.01% | 1037 |
|
|
2014
Q2 | $47K | Hold |
10,324
| – | – | ﹤0.01% | 1069 |
|
|
2014
Q1 | $49K | Hold |
10,324
| – | – | ﹤0.01% | 1046 |
|
|
2013
Q4 | $52K | Hold |
10,324
| – | – | ﹤0.01% | 1038 |
|
|
2013
Q3 | $64K | Buy |
+10,324
| New | +$61.3K | 0.01% | 978 |
|
Other funds holding ARRY
Ameritas Investment Partners's ARRY Position: Q3 2019 in Review
Ameritas Investment Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 18,964 shares — an estimated $879K sold.
Ameritas Investment Partners first reported a position in ARRY in Q3 2013 and held it in 24 quarters. The position peaked at $879K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Ameritas Investment Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Ameritas Investment Partners sold 18,964 Array Biopharma Inc shares in Q3 2019, an estimated $879K.
- Ameritas Investment Partners first reported a position in Array Biopharma Inc in Q3 2013 and held it in 24 quarters.
- Ameritas Investment Partners's Array Biopharma Inc position peaked at $879K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Ameritas Investment Partners's 13F filing for Q3 2019, filed 14 Nov 2019.